Literature DB >> 26408682

Hyaluronic Acid Inhibitor 4-Methylumbelliferone Activates the Intrinsic Apoptosis Pathway in K562 Chronic Myelogenous Leukemia Cells.

Hao Ban1, Olga Uchakina1, Robert James McKallip2.   

Abstract

BACKGROUND: As an inhibitor of hyaluronic acid (HA) synthesis, 4-methylumbelliferone (4-MU) has been shown to induce apoptosis of various types of cancer cells. However, the potential impact of 4-MU-induced apoptosis on leukemia cells via modulation of HA is not well-known.
MATERIALS AND METHODS: We examined apoptosis of chronic myelogenous leukemia (CML) cells after treatment with 4-MU using annexin V/propidium iodide (V/PI) analysis and poly (ADP-ribose) polymerase (PARP) cleavage. We further examined the mechanisms of 4-MU-induced apoptosis by measuring mitochondrial membrane potential and reactive oxygen species generation. Using real-time PCR, and western blot analysis we examined signaling pathways involved in apoptosis.
RESULTS: The current study demonstrated that treatment of CML cells with 4-MU led to induction of apoptosis through PARP cleavage and loss of mitochondria membrane potential. Mechanistically, 4-MU led to increased p53 mRNA expression, elevated cytoplasmic protein levels of cytochrome c and B-cell lymphoma-2-associated X (BAX) and reduced levels of B-cell lymphoma-2 (BCL2) expression. Addition of exogenous soluble HA was able to protect 4-MU-exposed cells from apoptosis.
CONCLUSION: Our findings suggest that 4-MU induces apoptosis in CML cells by activating components associated with the intrinsic apoptosis pathway. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  4-Methylumbelliferone; Apoptosis; BCL2 family; K562 cells; ROS; mitochondria

Mesh:

Substances:

Year:  2015        PMID: 26408682

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.

Authors:  Yeonjung Yoon; Min Kyung Chae; Eun Jig Lee; Jin Sook Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-03       Impact factor: 3.117

2.  Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181.

Authors:  Jiangjiang Gong; Shunli Zheng; Lei Zhang; Yi Wang; Jiali Meng
Journal:  Med Sci Monit       Date:  2017-01-10

3.  4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer.

Authors:  Noor A Lokman; Zoe K Price; Emily K Hawkins; Anne M Macpherson; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancers (Basel)       Date:  2019-08-15       Impact factor: 6.639

4.  Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells.

Authors:  Sadaf Dorandish; Asana Williams; Sarah Atali; Sophia Sendo; Deanna Price; Colton Thompson; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

5.  Plant-Derived Molecule 4-Methylumbelliferone Suppresses FcεRI-Mediated Mast Cell Activation and Allergic Inflammation.

Authors:  Hui-Na Wang; Qiu-An Xiang; Hao-Hui Lin; Jie-Ning Chen; Wen-Jie Guo; Wan-Meng Guo; Xiang-Ning Yue; Zhen-Fu Zhao; Kunmei Ji; Jia-Jie Chen
Journal:  Molecules       Date:  2022-02-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.